Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T14:21:34.188Z.
Calculation as of: 2026-10-06T14:21:34.188Z.
Quote observation: 2026-10-06T14:12:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2576380beaab4b3cbce085b4235445012990db653f345db98d0cfe80ba67c11f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Dogwood Therapeutics, Inc.
Market Cap
$54.14M
Price/FCF Ratio
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO |
|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | $54.14M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $55.01M | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.42M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $55.97M | N/A |
| Apollomics, Inc. (APLM)vs › | $52.20M | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.37M | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $56.52M | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $51.62M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
